lyophilized peptides
A co-formulated research blend of cagrilintide and semaglutide for controlled laboratory comparison of amylin- and GLP-1-related signalling and analytical compatibility.
Core identifiers are presented in a concise technical format so research teams and distributors can evaluate the material quickly and request batch-specific documentation when needed.
CagriSema combines the amylin analogue cagrilintide with the GLP-1 analogue semaglutide. The blend is intended for controlled in-vitro research, comparative signalling studies, and analytical compatibility assessment.
Because CagriSema contains two defined peptides, it does not have a single molecular formula or molecular weight. Component documentation is available by batch.
Analytical documentation is organized around purity, identity, and batch traceability. Availability is confirmed for the specific specification and batch requested.
Chromatographic purity results are documented against the applicable batch specification.
Mass spectrometry support is available for molecular identity verification.
Certificate details can be provided for review before or with a qualified order.
Choose the required research specification when requesting availability, documentation, and a quotation.
Send the required specification and quantity. Our team will confirm current availability, documentation, and packaging options.
